Skip to main content Skip to navigation
We care about your privacy. Read about your rights and how we protect your data. Get Details

COVID-19 Update:Learn where you can get your child vaccinated, as well as other important facts about COVID-19.

Newsroom

  • Portrait of Young Girl Patient in Exam Room

    Leader in Care

    Throughout the Washington, D.C, region, the nation and the world, Children’s National Hospital is recognized for our expertise and innovation in pediatric care and as an advocate for all children.

    Read more

Latest News

Children’s National Hospital hosts First Lady and Dr. Fauci as they encourage families to get COVID vaccine

Twelve-year-old Skylah Jackson from Ward 8 in Washington, D.C., had a special guest in her support network while getting her COVID-19 vaccine today – the First Lady of the United States. First Lady Dr. Jill Biden and Dr. Anthony Fauci, the head of the National Institute of Allergy and Infectious Diseases, toured the COVID-19 vaccine clinic at Children’s National Hospital.

Prestigious annual pediatric medical device competition reveals five finalists

Five finalists have been named in the prestigious annual “Make Your Medical Device Pitch for Kids!” competition presented by the National Capital Consortium for Pediatric Device Innovation (NCC-PDI). Representing innovations in electrophysiology devices that treat congenital heart disease (CHD) and arrhythmias in pediatric patients, these five finalists now have access to a pediatric accelerator program led by MedTech Innovator and will compete for a share of $150,000 in grant funding from the U.S. Food and Drug Administration (FDA) in the final virtual pitch event in September 2021. The pediatric pitch event is part of the 9th Annual Symposium on Pediatric Device Innovation, co-located with the MedTech Conference, powered by AdvaMed.
Antibodies responding to covid-19 coronavirus, illustration

Immunocompromised pediatric patients showed T-cell activity and humoral immunity against SARS-CoV-2

According to data from a cohort of adult and pediatric patients with antibody deficiencies, patients that often fail to make protective immune responses to infections and vaccinations showed robust T-cell activity and humoral immunity against SARS-CoV-2 structural proteins. The new study, led by researchers at Children’s National Hospital, is the first to demonstrate a robust T-cell response against SARS-CoV-2 in immunocompromised patients.

Children’s National Hospital becomes part of the national CAUSE Clinical Research Network under a $3 million grant

The National Institute of Allergy and Infectious Diseases (NIAID) allocated $10 million in funding to establish the Childhood Asthma in the Urban Setting (CAUSE) network. The NIAID plans to increase this number by $70 million over seven years to support the network. Children’s National Hospital will be part of the new research network, which is a 7-year consortium comprised of seven clinical sites in six different cities that will join forces to perform mechanistic and translational studies examining the basic immunology of pediatric asthma among urban, under-resourced, and largely minority children and adolescents.

Firearms injuries involving young children in the United States during the COVID-19 pandemic

A recent study published in Pediatrics found that the COVID-19 pandemic is associated with a surge in firearm injuries in young children and inflicted by young children. The findings, led by Children’s National Hospital experts, show that the COVID-19 pandemic is associated with a surge in fatal and nonfatal firearm injuries both in young children and inflicted by young children.